A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- PharmaEssentia
- Study ID
- NCT05481151
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
- Polycythemia Vera
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- P1101 (Ropeginterferon alfa-2b-njft) — DRUGRopeginterferon alfa-2b-njft
- Ropeginterferon alfa-2b-njft (P1101) — DRUGRopeginterferon alfa-2b-njft
Study Details
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients with PV
Key Dates
- Start date
- Oct 26, 2022
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2025
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 111 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: P1101 250-350-500mcgPre-filled Syringe, Q2W starting at 250-350-500, SC injection
- Active Comparator: Ropeginterferon alfa-2b-njftPre-filled Syringe, Q2W starting at 100 up to 500 (50mcg increases), SC injection
Primary Outcome Measure
Compare efficacy, safety, and tolerability of P1101 utilizing 250-350-500 mcg compared to the current labeled dosing through assessing the proportion of subjects that are in a complete hematologic response at Week 24. [ Time Frame: 24 weeks ]
Locations (17)
Find similar trials in Jacksonville, FL
By research site
Baptist MD Anderson· Jacksonville, FLFort Wayne Medical Oncology and Hematology· Fort Wayne, INUniversity of Kansas Medical Center· Westwood, KSMercy Health· Paducah, KYTulane University Medical Center· New Orleans, LAAmerican Oncology Partners of Maryland PA (Center for Cancer & Blood Disorders)· Bethesda, MD
Related Studies
- Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraPHASE3 · Recruiting · Italfarmaco · Birmingham, Alabama
- A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Ann Arbor, Michigan
- MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)Recruiting · MPN Research Foundation · Chicago, Illinois
- INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)PHASE3 · Recruiting · Ono Pharmaceutical Co., Ltd. · Miami, Florida